Globus Historical Balance Sheet

GMED Stock  USD 66.31  0.11  0.17%   
Trend analysis of Globus Medical balance sheet accounts such as Short and Long Term Debt Total of 546.4 M or Other Current Liab of 320.6 M provides information on Globus Medical's total assets, liabilities, and equity, which is the actual value of Globus Medical to its prevalent stockholders. By breaking down trends over time using Globus Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Globus Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Globus Medical is a good buy for the upcoming year.

Globus Medical Inventory

890.54 Million

  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

About Globus Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Globus Medical at a specified time, usually calculated after every quarter, six months, or one year. Globus Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Globus Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Globus currently owns. An asset can also be divided into two categories, current and non-current.

Globus Medical Balance Sheet Chart

At present, Globus Medical's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 320.6 M, whereas Current Deferred Revenue is forecasted to decline to about 9.6 M.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Globus Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Globus Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Most accounts from Globus Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.At present, Globus Medical's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 320.6 M, whereas Current Deferred Revenue is forecasted to decline to about 9.6 M.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total5.1M6.0M520.4M546.4M
Total Assets2.0B2.1B5.1B5.3B

Globus Medical balance sheet Correlations

0.70.490.530.690.730.70.680.720.270.830.760.540.690.540.550.90.680.990.530.650.750.580.590.660.74
0.70.930.90.991.00.841.00.790.670.580.960.931.00.810.590.671.00.710.950.990.990.980.970.981.0
0.490.930.960.950.910.670.940.610.820.260.880.920.940.680.40.40.950.521.00.960.890.990.990.90.92
0.530.90.960.930.880.670.910.60.880.270.910.810.90.630.350.430.920.570.960.930.870.950.960.880.9
0.690.990.950.930.990.830.990.770.730.530.960.910.990.760.550.630.990.710.970.990.980.990.980.970.99
0.731.00.910.880.990.860.990.810.630.630.960.921.00.830.620.70.990.730.930.990.990.960.960.981.0
0.70.840.670.670.830.860.820.90.420.710.790.710.830.670.660.780.810.70.730.820.830.770.770.90.86
0.681.00.940.910.990.990.820.770.680.560.950.931.00.820.590.651.00.690.960.990.990.980.980.970.99
0.720.790.610.60.770.810.90.770.310.780.750.690.780.720.630.830.770.710.660.770.790.710.70.850.8
0.270.670.820.880.730.630.420.680.31-0.030.680.530.670.290.020.140.70.320.80.710.610.760.780.640.66
0.830.580.260.270.530.630.710.560.78-0.030.610.410.570.640.660.930.550.790.310.50.650.410.390.590.6
0.760.960.880.910.960.960.790.950.750.680.610.830.950.770.510.680.970.770.890.950.960.930.920.940.97
0.540.930.920.810.910.920.710.930.690.530.410.830.930.810.580.50.920.550.930.940.90.940.930.890.91
0.691.00.940.90.991.00.831.00.780.670.570.950.930.810.580.651.00.690.960.990.990.980.980.980.99
0.540.810.680.630.760.830.670.820.720.290.640.770.810.810.70.670.810.540.70.780.850.750.730.810.8
0.550.590.40.350.550.620.660.590.630.020.660.510.580.580.70.720.550.540.440.560.640.490.480.550.61
0.90.670.40.430.630.70.780.650.830.140.930.680.50.650.670.720.630.880.450.60.710.520.520.670.7
0.681.00.950.920.990.990.811.00.770.70.550.970.921.00.810.550.630.690.960.990.980.980.980.970.99
0.990.710.520.570.710.730.70.690.710.320.790.770.550.690.540.540.880.690.560.660.750.610.610.670.74
0.530.951.00.960.970.930.730.960.660.80.310.890.930.960.70.440.450.960.560.980.910.991.00.920.94
0.650.990.960.930.990.990.820.990.770.710.50.950.940.990.780.560.60.990.660.980.970.990.990.970.99
0.750.990.890.870.980.990.830.990.790.610.650.960.90.990.850.640.710.980.750.910.970.950.940.960.99
0.580.980.990.950.990.960.770.980.710.760.410.930.940.980.750.490.520.980.610.990.990.951.00.950.97
0.590.970.990.960.980.960.770.980.70.780.390.920.930.980.730.480.520.980.611.00.990.941.00.950.96
0.660.980.90.880.970.980.90.970.850.640.590.940.890.980.810.550.670.970.670.920.970.960.950.950.98
0.741.00.920.90.991.00.860.990.80.660.60.970.910.990.80.610.70.990.740.940.990.990.970.960.98
Click cells to compare fundamentals

Globus Medical Account Relationship Matchups

Globus Medical balance sheet Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding102.0M101.0M103.6M102.6M114.6M104.1M
Total Assets1.5B1.7B2.0B2.1B5.1B5.3B
Other Current Liab6.7M5.8M11.8M106.5M305.3M320.6M
Total Current Liabilities111.4M120.8M140.2M159.2M392.3M412.0M
Total Stockholder Equity1.4B1.5B1.7B1.8B4.0B4.2B
Other Liab17.1M52.4M75.7M70.5M81.1M85.2M
Property Plant And Equipment Net199.8M216.9M221.1M243.7M646.9M679.2M
Current Deferred Revenue5.4M8.1M12.0M14.1M18.4M9.6M
Net Debt(193.2M)(234.6M)(188.0M)(144.5M)53.1M55.8M
Retained Earnings1.0B1.0B1.2B1.2B1.1B764.6M
Accounts Payable24.6M18.2M22.0M36.1M56.7M59.5M
Cash195.7M239.4M193.1M150.5M467.3M490.7M
Non Current Assets Total844.6M857.7M1.1B1.1B3.2B3.3B
Non Currrent Assets Other21.7M32.0M36.3M43.3M78.6M82.5M
Other Assets25.2M209.8M60.8M92.2M106.0M111.3M
Cash And Short Term Investments311.5M426.7M443.4M446.1M517.8M342.9M
Net Receivables162.4M148.1M165.7M217.3M504.9M530.1M
Liabilities And Stockholders Equity1.5B1.7B2.0B2.1B5.1B5.3B
Non Current Liabilities Total18.2M52.4M75.7M70.5M695.8M730.6M
Inventory196.3M229.2M237.0M299.0M848.1M890.5M
Other Current Assets17.2M17.8M18.4M21.0M44.6M46.8M
Other Stockholder Equity357.3M457.2M553.8M631.0M2.9B3.0B
Total Liab129.6M173.2M215.9M229.8M1.1B1.1B
Property Plant And Equipment Gross199.8M216.9M526.7M586.8M1.1B1.1B
Total Current Assets687.5M821.8M864.5M983.3M1.9B2.0B
Accumulated Other Comprehensive Income(2.9M)4.0M(6.8M)(24.6M)(10.2M)(9.7M)
Short Term Debt74.7M88.7M94.4M2.5M12.0M11.4M
Property Plant Equipment202.3M216.9M221.1M243.7M280.3M146.5M
Good Will128.8M156.7M179.7M197.5M1.4B1.5B
Intangible Assets78.8M86.9M68.7M63.6M924.6M970.8M
Net Tangible Assets1.2B1.3B1.5B1.6B1.8B981.4M
Short Term Investments115.8M187.3M250.4M295.6M50.5M48.0M
Capital Surpluse357.3M457.2M553.8M631.0M725.6M761.9M
Non Current Liabilities Other12.2M46.2M71.4M68.8M102.9M108.1M
Long Term Investments409.5M358.5M562.5M495.9M75.4M71.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Globus Stock

When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
0.54
Revenue Per Share
15.579
Quarterly Revenue Growth
1.193
Return On Assets
0.0527
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.